Publication Beamlines Strategic Pillar
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 요한 프란손; 로빈 매튜 할렛; 모니카 파스쿠알 가르시아 et al. (2021). Combination of LIF inhibitor and PD-1 axis inhibitor for use in treating cancer. Patent Number: KR20210021287A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 파트리샤 앤 깁린; 잔느 마그람 et al. (2021). Combination of LIF inhibitors and platinum-based anti-neoplastic agents for use in treating cancer. Patent Number: KR20210022065A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 피터 에드워드 베일리스; 아지타 제가나탄 et al. (2021). Methods for improving response to anti-LIF antibody treatment in a subject with cancer. Patent Number: KR20210024007A.
Andreas Ernst; Sachdev Sidhu; Linda Beatty (2021). Specific active site inhibitors of enzymes or substrate binding partners and methods of producing same. Patent Number: CA3053192C.
Attar Ricardo; D Powers Gordon; Gaudet Francois; Pillarisetti Kodandaram; Thomas Baldwin Eric et al. (2021). BCMA Antibodies, BCMA and CD3 Bispecific Antigen-Binding Molecules, and Their Uses. Patent Number: JO3799B1.
Dorothea KOMINOS; Jie Zhang; Alla Pritsker; Matthew Davison; Nicolas Baurin et al. (2021). Antibodies to bradykinin b1 receptor ligands. Patent Number: MY184037A.
Edward Sargent; Cao-Thang DINH; Francisco PELAYO GARCIA DE ARQUER; Alexander IP (2021). Composite multilayered electrocatalysts for co2 reduction and associated methods. Patent Number: EP3571331B1.
Edward Sargent; Phil DE LUNA; Fanglin CHE; Yansong ZHOU (2021). Boron-doped copper catalysts for efficient conversion of co2 to multi-carbon hydrocarbons and associated methods. Patent Number: EP3784819A1.
Folgueira Judit Anido; Teixidor Ester Bonfill; Johan Fransson; Garcia Monica Pascual; Rigol Ester Planas et al. (2021). COMBINATION OF LIF INHIBITORS AND PD-1 AXIS INHIBITORS FOR USE IN THE TREATMENT OF CANCER. Patent Number: MA52231A.
Guo Shuaiqi; Voets Ilja; Davies Peter; Klose Karl (2021). Peptides for use in the treatment of cholera. Patent Number: NL2023527B1.
Hedda WARDEMANN; Rajagopal MURUGAN; Tizian DECKER; Elena Levashina; Guilia COSTA et al. (2021). Plasmodium antibodies. Patent Number: WO2021001351A1.
James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2021). Methods of identifying signaling modulators of the trimeric TNFa. Patent Number: US10883996B2.
Joan Seoane Suarez; Judit Anido Folgueira; Johan Fransson; Monica PASCUAL GARCIA; Ester BONFILL TEIXIDOR et al. (2021). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: EP3774895A1.
J·塞奥内苏亚雷斯; J·阿尼多富尔盖拉; J·弗兰森; R·M·哈勒特; M·帕斯夸尔加西亚 et al. (2021). Combination of LIF inhibitors and PD-1 axis inhibitors for the treatment of cancer. Patent Number: CN112585164A.
Kodandaram Pillarisetti; Eric Thomas Baldwin; Gordon D Powers; Rosa Maria Fernandes Cardoso; Ricardo Attar et al. (2021). Anti-BCMA antibodies, bispecific antigen-binding molecules that bind BCMA and CD3, and uses thereof. Patent Number: ES2814550T3.